SE0302487D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0302487D0
SE0302487D0 SE0302487A SE0302487A SE0302487D0 SE 0302487 D0 SE0302487 D0 SE 0302487D0 SE 0302487 A SE0302487 A SE 0302487A SE 0302487 A SE0302487 A SE 0302487A SE 0302487 D0 SE0302487 D0 SE 0302487D0
Authority
SE
Sweden
Prior art keywords
sup
novel compounds
compounds
racemates
tautomers
Prior art date
Application number
SE0302487A
Other languages
English (en)
Swedish (sv)
Inventor
Peter Hansen
Hans Loenn
Antonios Nikitidis
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29212489&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0302487(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302487A priority Critical patent/SE0302487D0/xx
Publication of SE0302487D0 publication Critical patent/SE0302487D0/xx
Priority to TW093127678A priority patent/TW200526579A/zh
Priority to MXPA06002723A priority patent/MXPA06002723A/es
Priority to JP2006526856A priority patent/JP2007505902A/ja
Priority to DE602004019110T priority patent/DE602004019110D1/de
Priority to US10/572,640 priority patent/US20070043036A1/en
Priority to CNB2004800275174A priority patent/CN100439339C/zh
Priority to ES04775439T priority patent/ES2319300T3/es
Priority to UY28513A priority patent/UY28513A1/es
Priority to KR1020067005458A priority patent/KR20060096995A/ko
Priority to EP04775439A priority patent/EP1663974B1/en
Priority to UAA200602252A priority patent/UA84878C2/ru
Priority to AT04775439T priority patent/ATE420861T1/de
Priority to RU2006112427/04A priority patent/RU2348617C2/ru
Priority to BRPI0414570-4A priority patent/BRPI0414570A/pt
Priority to CA002538410A priority patent/CA2538410A1/en
Priority to AU2004272485A priority patent/AU2004272485B2/en
Priority to PCT/SE2004/001336 priority patent/WO2005026124A1/en
Priority to ARP040103354A priority patent/AR046083A1/es
Priority to SA4250300A priority patent/SA04250300B1/ar
Priority to IL173986A priority patent/IL173986A0/en
Priority to CO06026211A priority patent/CO5670357A2/es
Priority to ZA200602262A priority patent/ZA200602262B/xx
Priority to IS8394A priority patent/IS8394A/is
Priority to NO20061700A priority patent/NO20061700L/no
Priority to HK06109477.7A priority patent/HK1089167A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE0302487A 2003-09-18 2003-09-18 Novel compounds SE0302487D0 (sv)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE0302487A SE0302487D0 (sv) 2003-09-18 2003-09-18 Novel compounds
TW093127678A TW200526579A (en) 2003-09-18 2004-09-13 Novel compounds
AU2004272485A AU2004272485B2 (en) 2003-09-18 2004-09-15 2-pyridone derivatives as neutrophil elastase inhibitors and their use
PCT/SE2004/001336 WO2005026124A1 (en) 2003-09-18 2004-09-15 2-pyridone derivatives as netrophil elastase inhibitors and their use
UAA200602252A UA84878C2 (ru) 2003-09-18 2004-09-15 Производные 2-пиридона как ингибиторы нейтрофилов эластазы, фармацевтическая композиция на их основе, способ их получения
RU2006112427/04A RU2348617C2 (ru) 2003-09-18 2004-09-15 Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение
DE602004019110T DE602004019110D1 (de) 2003-09-18 2004-09-15 2-pyridonderivate als inhibitoren von neutrophilelastase und deren verwendung
US10/572,640 US20070043036A1 (en) 2003-09-18 2004-09-15 2-Pyridone derivatives as neutrophil elastase inhibitors and their use
CNB2004800275174A CN100439339C (zh) 2003-09-18 2004-09-15 用作嗜中性白细胞弹性蛋白酶抑制剂的2-吡啶酮衍生物及其用途
ES04775439T ES2319300T3 (es) 2003-09-18 2004-09-15 Derivados de 2-piridona como inhibidores de elastasa neutrofila y su uso.
UY28513A UY28513A1 (es) 2003-09-18 2004-09-15 Nuevos compuestos
KR1020067005458A KR20060096995A (ko) 2003-09-18 2004-09-15 중성구 엘라스타제 억제제로서의 2-피리돈 유도체 및 그의용도
EP04775439A EP1663974B1 (en) 2003-09-18 2004-09-15 2-pyridone derivatives as netrophil elastase inhibitors and their use
MXPA06002723A MXPA06002723A (es) 2003-09-18 2004-09-15 Derivados de 2-piridona como inhibidores de neutrofilo elastasa y su uso.
AT04775439T ATE420861T1 (de) 2003-09-18 2004-09-15 2-pyridonderivate als inhibitoren von neutrophilelastase und deren verwendung
JP2006526856A JP2007505902A (ja) 2003-09-18 2004-09-15 好中球エラスターゼ阻害剤としての２−ピリドン誘導体およびその使用
BRPI0414570-4A BRPI0414570A (pt) 2003-09-18 2004-09-15 derivados de 2-piridona como inibidores de elastase de neutrófilo e seu uso
CA002538410A CA2538410A1 (en) 2003-09-18 2004-09-15 2-pyridone derivatives as netrophil elastase inhibitors and their use
ARP040103354A AR046083A1 (es) 2003-09-18 2004-09-17 Derivados de 2 piridona como inhibidores de la elastasa de neutrofilos
SA4250300A SA04250300B1 (ar) 2003-09-18 2004-09-18 مشتقات 2_ بيريدون تعمل كمثبطات لانزيم ايلاستيز النتيروفيل واستخدامها
IL173986A IL173986A0 (en) 2003-09-18 2006-02-27 2-pyridone derivatives as netrophil elastase inhibitors and their use
CO06026211A CO5670357A2 (es) 2003-09-18 2006-03-15 Derivados de 2-piridona como inhibidores de elastasa neutrofila y su uso
ZA200602262A ZA200602262B (en) 2003-09-18 2006-03-17 2-Pyridone derivatives as neutrophil elastase inhibitors and their use
IS8394A IS8394A (is) 2003-09-18 2006-03-31 2-pýridónafleiður sem daukyrningselastasatálmar og notkun þeirra
NO20061700A NO20061700L (no) 2003-09-18 2006-04-18 2-pyridonderivater som neutrofil elastase inhibitorer og deres anvendelse
HK06109477.7A HK1089167A1 (en) 2003-09-18 2006-08-25 2-pyridone derivatives as netrophil elastase inhibitors and their use 2-

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302487A SE0302487D0 (sv) 2003-09-18 2003-09-18 Novel compounds

Publications (1)

Publication Number Publication Date
SE0302487D0 true SE0302487D0 (sv) 2003-09-18

Family

ID=29212489

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302487A SE0302487D0 (sv) 2003-09-18 2003-09-18 Novel compounds

Country Status (26)

Country Link
US (1) US20070043036A1 (xx)
EP (1) EP1663974B1 (xx)
JP (1) JP2007505902A (xx)
KR (1) KR20060096995A (xx)
CN (1) CN100439339C (xx)
AR (1) AR046083A1 (xx)
AT (1) ATE420861T1 (xx)
AU (1) AU2004272485B2 (xx)
BR (1) BRPI0414570A (xx)
CA (1) CA2538410A1 (xx)
CO (1) CO5670357A2 (xx)
DE (1) DE602004019110D1 (xx)
ES (1) ES2319300T3 (xx)
HK (1) HK1089167A1 (xx)
IL (1) IL173986A0 (xx)
IS (1) IS8394A (xx)
MX (1) MXPA06002723A (xx)
NO (1) NO20061700L (xx)
RU (1) RU2348617C2 (xx)
SA (1) SA04250300B1 (xx)
SE (1) SE0302487D0 (xx)
TW (1) TW200526579A (xx)
UA (1) UA84878C2 (xx)
UY (1) UY28513A1 (xx)
WO (1) WO2005026124A1 (xx)
ZA (1) ZA200602262B (xx)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200500341A (en) * 2002-11-12 2005-01-01 Astrazeneca Ab Novel compounds
SE0302486D0 (sv) * 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
TW200700392A (en) * 2005-03-16 2007-01-01 Astrazeneca Ab Novel compounds
EA015252B1 (ru) 2005-05-10 2011-06-30 Интермьюн, Инк. Способ модуляции стресс-активированной протеинкиназной системы
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
WO2007017670A1 (en) 2005-08-08 2007-02-15 Argenta Discovery Ltd. Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
EP1940458A4 (en) * 2005-09-29 2010-03-03 Univ Alberta COMPOSITIONS AND METHODS OF INHIBITING GRANZYME B
GB0605469D0 (en) * 2006-03-17 2006-04-26 Argenta Discovery Ltd Multimers of heterocyclic compounds and their use
TW200808763A (en) 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds I
TW200808771A (en) * 2006-05-08 2008-02-16 Astrazeneca Ab Novel compounds II
EP2077262A4 (en) 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVES AND THEIR USE
PL2089364T3 (pl) 2006-11-08 2013-11-29 Bristol Myers Squibb Co Związki pirydynonu
WO2009061271A1 (en) * 2007-11-06 2009-05-14 Astrazeneca Ab Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
CA2707785C (en) 2007-12-14 2015-11-03 Pulmagen Therapeutics (Asthma) Limited Indoles and their therapeutic use
JP5314050B2 (ja) 2008-01-23 2013-10-16 ブリストル−マイヤーズ スクイブ カンパニー ４−ピリジノン化合物および癌についてのその使用
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CN102099036B (zh) 2008-06-03 2015-05-27 英特芒尼公司 用于治疗炎性疾患和纤维化疾患的化合物和方法
GB0902648D0 (en) 2009-02-17 2009-04-01 Argenta Discovery Ltd Pharmaceutical compounds and compositions
CN102395586A (zh) 2009-02-17 2012-03-28 奇斯药制品公司 作为p38map激酶抑制剂的三唑并吡啶衍生物
TW201036957A (en) 2009-02-20 2010-10-16 Astrazeneca Ab Novel salt 628
WO2011039528A1 (en) * 2009-10-02 2011-04-07 Astrazeneca Ab 2-pyridone compounds used as inhibitors of neutrophil elastase
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
CN102596908A (zh) * 2009-12-08 2012-07-18 贝林格尔.英格海姆国际有限公司 用于制备取代的吲唑和氮杂吲唑化合物的中间体的合成方法
GB201009731D0 (en) 2010-06-10 2010-07-21 Pulmagen Therapeutics Inflamma Kinase inhibitors
JP5709999B2 (ja) 2011-08-01 2015-04-30 大日本住友製薬株式会社 ウラシル誘導体およびその医薬用途
ES2612259T3 (es) 2011-12-09 2017-05-16 Chiesi Farmaceutici S.P.A. Inhibidores de cinasa
EP2788345B1 (en) 2011-12-09 2020-06-10 Chiesi Farmaceutici S.p.A. Derivatives of 4-hydroxy-1,2,3,4-tetrahydronaphtalen-1-yl urea and their use in the treatment of, inter alia, diseases of the respiratory tract
RU2623734C9 (ru) 2011-12-09 2017-09-18 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Ингибиторы киназы
US20140057920A1 (en) 2012-08-23 2014-02-27 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
US9102624B2 (en) 2012-08-23 2015-08-11 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
US20140057926A1 (en) 2012-08-23 2014-02-27 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US9181242B2 (en) 2013-06-06 2015-11-10 Chiesi Farmaceutici S.P.A. Kinase inhibitors
US9221807B2 (en) * 2014-02-21 2015-12-29 Boehringer Ingelheim International Gmbh Substituted pyridones and pyrazinones and their use as inhibitors of neutrophil elastase activity
CN110452216B (zh) 2014-04-02 2022-08-26 英特穆恩公司 抗纤维化吡啶酮类
UY36875A (es) 2015-09-02 2017-03-31 Glaxosmithkline Intellectual Property (No 2) Ltd Composiciones inhibidoras de bromodominios para el tratamiento de diversas enfermedades
TW201720828A (zh) 2015-11-23 2017-06-16 赫孚孟拉羅股份公司 治療性化合物及組合物以及其使用方法
WO2017108736A1 (en) 2015-12-23 2017-06-29 Chiesi Farmaceutici S.P.A. N-[3-(3-{4-[[1,2,4]triazolo[4,3-a]pyridin-6-yloxy]-1,2,3,4-tetrahydro-naphthalen-1-yl} -ureido)-phenyl]-methanesulfonamide derivatives and their use as p38 mapk inhibitors
AR107164A1 (es) 2015-12-23 2018-03-28 Chiesi Farm Spa INHIBIDORES DE QUINASA p38
EP3394059B1 (en) 2015-12-23 2020-11-25 Chiesi Farmaceutici S.p.A. 1-(3-tert-butyl-phenyl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro- naphthalen-1-yl)-urea derivatives and their use as p38 mapk inhibitors
WO2017191098A1 (en) 2016-05-05 2017-11-09 F. Hoffmann-La Roche Ag Pyrazole derivatives, compositions and therapeutic use thereof
EP3510030B1 (en) 2016-09-06 2023-03-22 F. Hoffmann-La Roche AG 8-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereof
KR20190100337A (ko) 2016-12-29 2019-08-28 에프. 호프만-라 로슈 아게 피라졸로피리미딘 화합물 및 이의 사용 방법
EP3596072B1 (en) 2017-03-14 2022-06-22 F. Hoffmann-La Roche AG Pyrazolochlorophenyl compounds, compositions and methods of use thereof
CN110678467B (zh) 2017-05-22 2023-06-13 豪夫迈·罗氏有限公司 治疗化合物和组合物及其使用方法
BR112019024322A2 (pt) 2017-05-22 2020-06-16 F. Hoffmann-La Roche Ag Compostos e composições terapêuticos e métodos de uso dos mesmos
US10364245B2 (en) 2017-06-07 2019-07-30 Chiesi Farmaceutici S.P.A. Kinase inhibitors
JP7339263B2 (ja) 2018-01-15 2023-09-05 エフ． ホフマン－ラ ロシュ アーゲー Ｊａｋ阻害剤としてのピラゾロピリミジン化合物
CN111683976B (zh) 2018-02-05 2022-11-18 生物辐射实验室股份有限公司 具有阴离子交换-疏水混合模式配体的色谱树脂
CN110192947B (zh) * 2019-05-28 2022-01-04 河南省超亚医药器械有限公司 一种小儿肺部热敷贴
CN110192948B (zh) * 2019-05-28 2022-01-04 河南省超亚医药器械有限公司 一种小儿腹部热敷贴
CN114008050A (zh) 2019-06-18 2022-02-01 豪夫迈·罗氏有限公司 Jak激酶的吡唑并嘧啶芳基醚抑制剂及其用途
WO2020257145A1 (en) 2019-06-18 2020-12-24 Genentech, Inc. Pyrazolopyrimidine sulfone inhibitors of jak kinases and uses thereof
TW202115069A (zh) 2019-06-18 2021-04-16 瑞士商赫孚孟拉羅股份公司 Ｊａｋ激酶之經四唑取代之吡唑并嘧啶抑制劑及其用途
BR112022004861A2 (pt) 2019-09-17 2022-06-07 Univ Duke Alvelestat para uso no tratamento de rejeição de transplante, síndrome de bronquiolite obliterante e doença de transplante versus hospedeiro
IL297211A (en) 2020-04-16 2022-12-01 Mereo Biopharma 4 Ltd Methods involving the neutrophil elastase inhibitor albalstat for the treatment of respiratory disease mediated by alpha-1 antitrypsin deficiency
TW202325294A (zh) 2021-10-20 2023-07-01 英商梅瑞奧生物製藥４有限公司 用於治療纖維化之嗜中性球彈性蛋白酶抑制劑
CN114057630B (zh) * 2021-12-23 2023-06-02 郑州大学 吡非尼酮衍生物及其合成方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207145D0 (en) * 1991-04-18 1992-05-13 Ici Plc Heterocyclic amides
US5521179A (en) * 1991-04-18 1996-05-28 Zeneca Limited Heterocyclic amides
ES2330719T3 (es) * 2000-12-28 2009-12-15 SHIONOGI & CO., LTD. Derivados de 2-piridona con afinidad para el receptor cannabinoide de tipo 2.
GB0129260D0 (en) * 2001-12-06 2002-01-23 Eisai London Res Lab Ltd Pharmaceutical compositions and their uses
GB2383326A (en) * 2001-12-20 2003-06-25 Bayer Ag Antiinflammatory dihydropyridines
WO2003053930A1 (en) * 2001-12-20 2003-07-03 Bayer Healthcare Ag 1,4-dihydro-1,4-diphenylpyridine derivatives
TW200500341A (en) * 2002-11-12 2005-01-01 Astrazeneca Ab Novel compounds
SE0302486D0 (sv) * 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
DE602004019110D1 (de) 2009-03-05
ZA200602262B (en) 2007-07-25
ATE420861T1 (de) 2009-01-15
CO5670357A2 (es) 2006-08-31
WO2005026124A1 (en) 2005-03-24
EP1663974A1 (en) 2006-06-07
RU2006112427A (ru) 2007-11-10
EP1663974B1 (en) 2009-01-14
NO20061700L (no) 2006-04-18
ES2319300T3 (es) 2009-05-06
CN100439339C (zh) 2008-12-03
IS8394A (is) 2006-03-31
UY28513A1 (es) 2005-04-29
MXPA06002723A (es) 2006-06-06
KR20060096995A (ko) 2006-09-13
AR046083A1 (es) 2005-11-23
CN1856467A (zh) 2006-11-01
BRPI0414570A (pt) 2006-11-07
UA84878C2 (ru) 2008-12-10
US20070043036A1 (en) 2007-02-22
IL173986A0 (en) 2006-07-05
TW200526579A (en) 2005-08-16
RU2348617C2 (ru) 2009-03-10
AU2004272485A1 (en) 2005-03-24
SA04250300B1 (ar) 2008-09-07
HK1089167A1 (en) 2006-11-24
AU2004272485B2 (en) 2008-03-13
CA2538410A1 (en) 2005-03-24
JP2007505902A (ja) 2007-03-15

Similar Documents

Publication Publication Date Title
SE0302487D0 (sv) Novel compounds
SE0302324D0 (sv) Novel compounds
SE0302486D0 (sv) Novel compounds
SE0302323D0 (sv) Novel compounds
MY137133A (en) Novel compounds
MX2007009372A (es) Nuevos compuestos ii derivados de 2-piridina como inhibidores de elastasa neutrofila.
SE0202463D0 (sv) Novel compounds
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
SE0302139D0 (sv) Novel compounds
ATE386725T1 (de) Heterocyclylverbindungen
SE0203304D0 (sv) Novel Coumpounds
SE0102055D0 (sv) New Compounds
SE0302756D0 (sv) Novel Compounds
SE0303280D0 (sv) Novel compounds
SE0202461D0 (sv) Novel compounds
DE60210981D1 (de) Heteroarylheteroalkylamin derivate und deren verwendung als inhibitoren der stickoxidsynthase
ATE265423T1 (de) Neue phenylheteroalkylamin-derivate
SE9904676D0 (sv) Novel compounds
SE0403118D0 (sv) New compounds 2
SE9901901D0 (sv) Compounds
SE0102640D0 (sv) Novel compounds
SE0403117D0 (sv) New compounds 1
SE0103325D0 (sv) Novel compounds
SE0302120D0 (sv) Novel compounds
SE0202280D0 (sv) Novel compounds